Pharmaceuticals & Life Sciences · Real-World Evidence & Outcomes Research
Real-World Evidence Generation & Analysis
Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.
What You Do Today
Design and execute real-world evidence studies using claims databases, EHR data, patient registries, and wearable device data. Generate evidence on treatment patterns, comparative effectiveness, safety, and economic outcomes for regulatory submissions, payer negotiations, and medical communications.
AI Technologies
Roles Involved
How It Works
NLP extracts structured clinical data from unstructured EHR notes at scale. Causal inference methods address confounding in observational data. Federated learning enables multi-site analyses without moving patient data across institutional boundaries. AI automates the identification of appropriate comparator cohorts.
What Changes
RWE generation accelerates from months to weeks. Federated learning enables analyses across datasets that were previously siloed. The range of questions answerable with RWD expands significantly.
What Stays the Same
Designing studies that produce valid causal inferences from observational data, interpreting results in clinical context, and defending RWE to skeptical regulators and payers require deep methodological and clinical expertise.
Evidence & Sources
- •FDA RWE framework guidance
- •ISPE guidelines for RWE studies
Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.
Last reviewed: March 2026
What To Do Next
This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.
Establish Your Baseline
Know where you are before you move
Before adopting AI tools for real-world evidence generation & analysis, document your current state in real-world evidence & outcomes research.
Without a baseline, you can't tell whether AI actually improved real-world evidence generation & analysis or just changed who does it.
Define Your Measures
What to track and how to calculate it
report delivery time
How to calculate
Measure report delivery time for real-world evidence generation & analysis before and after AI adoption. Pull from your data warehouse.
Why it matters
This is the most direct indicator of whether AI is adding value to real-world evidence & outcomes research.
self-service adoption rate
How to calculate
Track self-service adoption rate using the same methodology you use today. Don't change how you measure just because you changed how you work.
Why it matters
Speed without quality is just faster mistakes. Measure both together.
Start These Conversations
Who to talk to and what to ask
VP Data or Chief Data Officer
“What's our plan for AI in real-world evidence & outcomes research? Are we piloting, planning, or waiting?”
This tells you whether to experiment quietly or push for formal investment in real-world evidence generation & analysis.
your data warehouse administrator or vendor
“What AI capabilities exist in our current data warehouse that we're not using? Most platforms are adding AI features faster than teams adopt them.”
The cheapest AI adoption is the features already included in your existing license.
a practitioner in real-world evidence & outcomes research at another organization
“Have you deployed AI for real-world evidence generation & analysis? What worked, what didn't, and what would you do differently?”
Peer experience is more useful than vendor demos. Find someone who has actually done this.
Check Your Prerequisites
Confirm readiness before you invest
Check items as you confirm them.